Literature DB >> 29268318

Molecular mechanisms of pathological tumor transformation and their clinical implications: predictors of pulmonary adenocarcinoma transformation into small cell carcinoma.

Maria-Rosa Ghigna1, Vincent Thomas De Montpréville1.   

Abstract

Entities:  

Year:  2017        PMID： 29268318      PMCID： PMC5723871          DOI： 10.21037/jtd.2017.09.15

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  24 in total

1.  Small-cell carcinoma in the setting of pulmonary adenocarcinoma: new insights in the era of molecular pathology.

Authors:  Emma Norkowski; Maria-Rosa Ghigna; Ludovic Lacroix; Thierry Le Chevalier; Élie Fadel; Philippe Dartevelle; Peter Dorfmuller; Vincent Thomas de Montpréville
Journal:  J Thorac Oncol       Date:  2013-10       Impact factor: 15.609

Review 2.  Advances in target therapy in lung cancer.

Authors:  Jean-Paul Sculier; Thierry Berghmans; Anne-Pascale Meert
Journal:  Eur Respir Rev       Date:  2015-03

Review 3.  KRAS oncogene in lung cancer: focus on molecularly driven clinical trials.

Authors:  Emmanuelle Kempf; Benoît Rousseau; Benjamin Besse; Luis Paz-Ares
Journal:  Eur Respir Rev       Date:  2016-03

4.  Mixed small cell and non-small cell lung cancer.

Authors:  D J Adelstein; J F Tomashefski; N J Snow; T P Horrigan; J D Hines
Journal:  Chest       Date:  1986-05       Impact factor: 9.410

Review 5.  Biomarkers for efficacy of adjuvant chemotherapy following complete resection in NSCLC stages I-IIIA.

Authors:  Sandra Wallerek; Jens Benn Sørensen
Journal:  Eur Respir Rev       Date:  2015-06

6.  EGFR and KRAS molecular genotyping for pulmonary carcinomas: Feasibility of a simple and rapid technique implementable in any department of pathology.

Authors:  Vincent Thomas De Montpréville; Maria-Rosa Ghigna; Ludovic Lacroix; Antoinette Lemoine; Benjamin Besse; Olaf Mercier; Élie Fadel; Peter Dorfmuller; Thierry Le Chevalier
Journal:  Pathol Res Pract       Date:  2017-03-30       Impact factor: 3.250

Review 7.  Management of CML-blast crisis.

Authors:  Rüdiger Hehlmann; Susanne Saußele; Astghik Voskanyan; Richard T Silver
Journal:  Best Pract Res Clin Haematol       Date:  2016-10-20       Impact factor: 3.020

8.  Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers.

Authors:  Helena A Yu; Maria E Arcila; Natasha Rekhtman; Camelia S Sima; Maureen F Zakowski; William Pao; Mark G Kris; Vincent A Miller; Marc Ladanyi; Gregory J Riely
Journal:  Clin Cancer Res       Date:  2013-03-07       Impact factor: 12.531

9.  Patterns in lung cancer incidence rates and trends by histologic type in the United States, 2004-2009.

Authors:  Keisha A Houston; S Jane Henley; Jun Li; Mary C White; Thomas B Richards
Journal:  Lung Cancer       Date:  2014-08-12       Impact factor: 5.705

10.  Frequent amplification of receptor tyrosine kinase genes in welldifferentiated/ dedifferentiated liposarcoma.

Authors:  Naofumi Asano; Akihiko Yoshida; Sachiyo Mitani; Eisuke Kobayashi; Bunsyo Shiotani; Motokiyo Komiyama; Hiroyuki Fujimoto; Hirokazu Chuman; Hideo Morioka; Morio Matsumoto; Masaya Nakamura; Takashi Kubo; Mamoru Kato; Takashi Kohno; Akira Kawai; Tadashi Kondo; Hitoshi Ichikawa
Journal:  Oncotarget       Date:  2017-02-21
View more
  1 in total

1.  Is transformed small cell lung cancer (SCLC) different from de novo SCLC?

Authors:  Cheol-Kyu Park; In-Jae Oh; Young-Chul Kim
Journal:  Transl Cancer Res       Date:  2019-04       Impact factor: 1.241
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.